China Renaissance-backed Bloomage Biotech raises $338m in Shanghai IPO

China Renaissance-backed Bloomage Biotech raises $338m in Shanghai IPO

06 November, 2019

Bloomage BioTech China Renaissance Hyaluronic Acid

Printed by Unregistered user on Sat, 30 Aug 2025 07:34:18 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Quectel Wireless launches IPO on Shanghai Stock Exchange

Hong Kong biotech firms seek listings on China’s Star Board

Read more from Greater China

Earnings and Results

BYD’s quarterly profit falls for first time in over 3 years as price wars bite

Earnings and Results

Alibaba misses Q1 revenue estimates despite strong cloud show